The landscape of modern therapeutics is rapidly evolving, and peptides have emerged as a dominant topic of interest across various medical and wellness disciplines
In a 56-day phase-2 trial, 9 participants with severe dry eye syndrome were treated with synthetic TB4 eye drops or placebo for 28 days, followed by a 28-day observational period
The absorbance was measured using a microplate reader (Molecular Device, Menlo Park, CA, USA) at a wavelength of 490 nm
The choice depends on the type of pain, MRI findings, urgency of pain relief, age, medical risk, previous treatments, and whether the main goal is rapid pain control, lower numbness risk, diagnostic clarification, or long-term neuromodulation